APO-SITAGLIPTIN-METFORMIN · 50 MG + 1000 MG · TABLET

Médicament · Health Canada · Canada

DIN 02435799
Code de médicament DPD 92014
ATC A10BD07
AIG 0252656003

Ce que publie la source

Titulaire: APOTEX INC
Forme: TABLET
Voies d’administration: ORAL
Statut administratif: authorised
Régime de délivrance: PRESCRIPTION
Prescription: Sur ordonnance ou à délivrance restreinte

Noms permettant de trouver cette fiche

Données complètes de la source

ca:health-canada:products:92014

{
  "din": "02435799",
  "form": "TABLET",
  "name": "APO-SITAGLIPTIN-METFORMIN · 50 MG + 1000 MG · TABLET",
  "holder": "APOTEX INC",
  "routes": [
    "ORAL"
  ],
  "smpcUrl": null,
  "atcCodes": [
    "A10BD07"
  ],
  "drugCode": "92014",
  "marketed": true,
  "packages": [
    {
      "upc": "",
      "size": "",
      "type": "",
      "typeFr": "",
      "drugCode": "92014",
      "sizeUnit": "",
      "sizeUnitFr": "",
      "information": "60/180/500"
    }
  ],
  "brandName": "APO-SITAGLIPTIN-METFORMIN",
  "updatedAt": "03-FEB-2026",
  "useDomain": "human",
  "descriptor": null,
  "leafletUrl": null,
  "statusDate": "29-JAN-2026",
  "biosimilars": [],
  "brandNameFr": null,
  "descriptorFr": null,
  "productClass": "Human",
  "publishedDin": "02435799",
  "sourceStatus": "MARKETED",
  "supplyRegime": "PRESCRIPTION",
  "targetSpecies": [],
  "categorization": null,
  "ingredientGroup": "0252656003",
  "publicationDate": "2026-11-02",
  "sourcePartition": "marketed",
  "dinNotApplicable": false,
  "activeIngredients": [
    {
      "base": "N",
      "code": "20179",
      "name": "SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE)",
      "unit": "MG",
      "nameFr": "Sitagliptine (Phosphate de sitagliptine monohydraté)",
      "strength": "50",
      "dosageUnit": null,
      "dosageValue": null,
      "strengthType": null,
      "suppliedIndicator": "I"
    },
    {
      "base": "N",
      "code": "10147",
      "name": "METFORMIN HYDROCHLORIDE",
      "unit": "MG",
      "nameFr": "Chlorhydrate de metformine",
      "strength": "1000",
      "dosageUnit": null,
      "dosageValue": null,
      "strengthType": null,
      "suppliedIndicator": "I"
    }
  ],
  "useDomainEvidence": {
    "basis": "publisher-field",
    "field": "class",
    "value": "Human",
    "version": 1,
    "sourceId": "ca.health-canada.dpd"
  },
  "identifierWarnings": [],
  "patientEligibility": "not-assessed",
  "numberOfIngredients": "2",
  "targetSpeciesStatus": "not-applicable",
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "pharmaceuticalStandards": []
}

Base de données sur les produits pharmaceutiques (DPD)

Source: Health Canada, Drug Product Database (DPD).

Date de collecte: 10 novembre 2026
Licence: Conditions de l’éditeur
Identifiant de la source: ca.health-canada.dpd

Source officielle

Ce que cette source n’établit pas

This is the complete published DPD extract, not the separately licensed natural health products database, the CCDD clinical terminology dataset or provincial formulary eligibility.
The publisher page advertises file dates independently of the products’ own last-update dates; neither is silently replaced by collection time.
Record identity is DRUG_CODE. DINs are verbatim eight-digit strings and can repeat across historical observations; Not Applicable/non applicable is retained but never indexed as a DIN.
Veterinary and disinfectant products are collected as separate kinds and excluded from Doctofam prescriptions. Radiopharmaceuticals retain their own kind.
Schedules C/D, homeopathic and prescription-recommended designations alone do not establish Rx/OTC classification; missing, mixed and unrecognised classifications remain unknown. Ethical is federally non-prescription professional use.
Package descriptions and UPC values are publisher observations, not unique package records. No pack identifier, interchangeability, stock or patient eligibility is inferred.
The actual therapeutic-class export has four columns rather than the current read-me’s seven; the fourth remains raw without an inferred meaning.
Corporate addresses are withheld from normalized and raw records. Original source archives remain retained as evidence. No product monograph URLs are published in these extracts, and no clinical documents are copied.
The linked legacy copyright notice requires permission for commercial reproduction. The Open Government portal also lists this dataset, but its current licence could not be verified during review; commercial derived-data reuse remains unconfirmed and the owner accepts this documented rights gap under the country brief.

Lisez cette fiche depuis votre propre logiciel

La même fiche, avec tous ses champs et sa provenance, est à portée d’une requête. Une clé API est gratuite et fonctionne immédiatement.

Obtenez votre clé API gratuite Lire la référence

GET /v1/drugs/record

curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=ca" \
  --data-urlencode "sourceId=ca.health-canada.dpd" \
  --data-urlencode "id=ca:health-canada:products:92014"